Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity
Authors
Keywords
Coronavirus, COVID-19, Interferon-γ-induced protein 10 (IP-10), Serum amyloid A (SAA), Cytokine storm syndrome (CSS)
Journal
LIFE SCIENCES
Volume 269, Issue -, Pages 119019
Publisher
Elsevier BV
Online
2021-01-15
DOI
10.1016/j.lfs.2021.119019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
- (2020) Huan Han et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum amyloid A is a predictor for prognosis of COVID ‐19
- (2020) Xiao‐Neng Mo et al. RESPIROLOGY
- Plasma CRP level is positively associated with the severity of COVID-19
- (2020) Wei Chen et al. Annals of Clinical Microbiology and Antimicrobials
- Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
- (2020) Francesco Di Gennaro et al. International Journal of Environmental Research and Public Health
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
- (2020) Yosra A. Helmy et al. Journal of Clinical Medicine
- C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
- (2020) Guyi Wang et al. Open Forum Infectious Diseases
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Mild versus severe COVID-19: Laboratory markers
- (2020) Thirumalaisamy P. Velavan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Hematological features of persons with COVID-19
- (2020) Qiubai Li et al. LEUKEMIA
- Abnormal immunity of non-survivors with COVID-19: predictors for mortality
- (2020) Yang Zhao et al. Infectious Diseases of Poverty
- Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults
- (2017) Mary S. Hayney et al. JOURNAL OF CLINICAL VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started